Related Experiment Video
Updated: Aug 11, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Primary systemic vasculitis: clinical features and mortality
S E Lane1, R A Watts, L Shepstone
1Department of Rheumatology, Ipswich Hospital, Heath Rd, Ipswich IP4 5PD, UK. suzanne.lane@ipswichhospital.nhs.uk
Background:
Wegener's granulomatosis (WG), Churg Strauss syndrome (CSS) and microscopic polyangiitis (MPA) are primary systemic vasculitides (PSV), the clinical features of which have been described from tertiary centres.
Aim:
To provide the first clinical description of MPA from a general hospital and compare clinical features with WG and CSS.
Design:
Retrospective analysis of patient records.
Methods:
Records of 99 PSV patients attending a single hospital, from 1988 to 2000, were reviewed for: clinical features, date/age at diagnosis, sex, duration of illness, anti-neutrophil cytoplasmic antibodies (ANCA), treatment, comorbidity and deaths. Cases were classified using ACR, CHCC and Lanham criteria/definitions. Birmingham vasculitis activity scores (BVAS) and damage index (VDI) were calculated. Survival was assessed using Cox proportional hazards model and standardized mortality ratios (SMRs).
Results:
Compared to previous reports there was more ENT (29%) and respiratory (29%) but less renal (92%) involvement in MPA, and less ENT involvement in WG (81%). CSS showed high neurological (72%), cardiovascular (28%) and gastrointestinal (17%) involvement and the highest median (range) VDI (p = 0.01 vs. WG; p = 0.001 vs. MPA). BVAS1 was significantly lower in MPA than in WG [median (range) 15 (4-29) vs. 21 (6-39), (p = 0.001)] but not in CSS [20 (7-28), p = 0.08]. SMR (95%CI) for PSV was 4.8 (3.0-6.6); 5-year survival was 45.1% for MPA, 75.9% for WG and 68.1% for CSS. Age was a significant risk, but only to the same extent as in the reference population. When age was adjusted for, no other significant factor was found.
Discussion:
The clinical characteristics seen here are similar to those in previous series. There are difficulties in using the MPA CHCC definitions in classification. There is a high proportion of neurological involvement in CSS, causing permanent damage. MPA may have a poorer prognosis than WG or CSS.
Insights
Microscopic polyangiitis (MPA) and other primary systemic vasculitides (PSV) were described from a general hospital. MPA showed distinct clinical features and a potentially poorer prognosis compared to Wegener's granulomatosis (WG) and Churg Strauss syndrome (CSS).
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Primary systemic vasculitides (PSV), including Wegener's granulomatosis (WG), Churg Strauss syndrome (CSS), and microscopic polyangiitis (MPA), are typically described from specialized tertiary centers.
- Understanding the clinical spectrum of these conditions in a general hospital setting is crucial for broader diagnostic and management insights.
Purpose of the Study:
- To present the first clinical description of microscopic polyangiitis (MPA) originating from a general hospital setting.
- To compare the clinical characteristics of MPA with those of Wegener's granulomatosis (WG) and Churg Strauss syndrome (CSS).
Main Methods:
- A retrospective analysis of 99 primary systemic vasculitis (PSV) patient records from a single general hospital between 1988 and 2000.
- Data collected included clinical features, demographics, diagnostic criteria (ACR, CHCC, Lanham), anti-neutrophil cytoplasmic antibody (ANCA) status, treatment, comorbidities, mortality, Birmingham vasculitis activity scores (BVAS), and vasculitis damage index (VDI).
- Survival analysis was performed using Cox proportional hazards models and standardized mortality ratios (SMRs).
Main Results:
- Microscopic polyangiitis (MPA) cases exhibited increased ear, nose, throat (ENT), and respiratory involvement but reduced renal involvement compared to previous reports.
- Churg Strauss syndrome (CSS) demonstrated high rates of neurological, cardiovascular, and gastrointestinal involvement, along with the highest median VDI.
- Microscopic polyangiitis (MPA) presented with a significantly lower BVAS than Wegener's granulomatosis (WG), and overall survival rates were lower for MPA (45.1%) compared to WG (75.9%) and CSS (68.1%).
Conclusions:
- The clinical presentation of primary systemic vasculitides (PSV) in a general hospital aligns with findings from tertiary centers, though classification criteria for MPA require refinement.
- Churg Strauss syndrome (CSS) is associated with significant neurological involvement and permanent damage.
- Microscopic polyangiitis (MPA) may carry a poorer prognosis than Wegener's granulomatosis (WG) or Churg Strauss syndrome (CSS).
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Bacterial Meningitis I: Introduction

